Hirsutism Treatment Market Size, Share, Opportunities, And Trends By Treatment Type (Medications, Procedures, Others), By Application (Upper Lip, Chin, Chest, Arms, Others), By End-User (Hospitals, Dermatology Clinics & Aesthetic Centers, Others), And By Geography - Forecasts From 2024 To 2029

The hirsutism treatment market is anticipated to grow rapidly during the projected period.

There are many treatment options for hirsutism, which is characterized by excessive and undesired hair growth in females with a male pattern distribution. Hormone levels can be regulated by medications like oral contraceptives or anti-androgen medications, or they can be inhibited by topical therapies like eflornithine creams. Permanent or temporary remedies are provided by hair removal techniques including electrolysis, laser hair removal, shaving, and waxing. A balanced diet and weight control are examples of lifestyle modifications that are helpful, particularly if hirsutism is connected to diseases like polycystic ovarian syndrome (PCOS).

Growth drivers for hirsutism treatment

The hirsutism treatment market is expanding rapidly due to various factors. The need for effective treatment alternatives has increased because of the rising frequency of hirsutism, which is frequently associated with illnesses including polycystic ovarian syndrome (PCOS) and hormonal imbalances. Early diagnosis and intervention are made possible via increased public and healthcare professional knowledge of hirsutism. A large number of patients are drawn to cosmetic operations due to the more effective and minimally invasive options provided by technological breakthroughs, especially in laser hair removal. The aging population on a worldwide scale, increased healthcare spending, and increased attention to women's health all contribute to the accessibility and affordability of hirsutism therapies.

Increasing prevalence of PCOS

The market for hirsutism treatments is significantly impacted by the increasing incidence of Polycystic Ovary Syndrome (PCOS), which generates a dynamic environment due to a rise in patient volume and awareness. Since PCOS is the primary cause of hirsutism, many people are seeking treatment for related symptoms, including excessive hair growth. As per the data published by the World Health Organization on June 2023, an estimated 8–13% of women who are of reproductive age have PCOS, and up to 70% of instances go untreated. Certain ethnic groups have a greater frequency of PCOS and are also more likely to have complications, particularly those connected to metabolic issues.

Increasing healthcare expenditure

The market for hirsutism treatments is positively impacted by rising healthcare spending because it makes it easier for people to access cutting-edge diagnostics, encourages the development of novel therapies through research and development, and supports all-inclusive patient care models. For instance, between 2020 and 2021, the total amount spent on healthcare in the United Kingdom increased by 9.4% in nominal terms and by 9.7% in real ones as declared by the Government of the United Kingdom. Although this was nominally far less than the rise in spending in 2020, in actual terms, this represents the greatest annual growth rate recorded for the duration of the period, which started in 1997.

Technological advancements in hair removal

Technological advancements in hair removal have fundamentally influenced the market since more precise, effective, and patient-friendly options are made available for hirsutism therapy. More precision and efficiency are provided by technological innovations such as strong pulsed light systems and laser hair removal, which attract patients suffering from hirsutism seeking longer-lasting treatments. The development of less intrusive and more flexible medicines ensures tailored approaches for various patient needs, minimizing side effects and improving overall safety. Furthermore, owing to portable devices, new treatment options are becoming available as these technologies develop.

Rising cosmetic concerns

Growing concerns about appearance have a substantial effect on the hirsutism treatments market. People who are trying to deal with the excessive hair growth that comes with hirsutism drive demand for cosmetic procedures including electrolysis, topical treatments, and laser hair removal. This trend highlights a developing sector that is centered on improving physical appearance. This in turn is driving ongoing research and development in hirsutism treatment solutions that satisfy patients and their cosmetic preferences.

The hirsutism treatment market in the North American region is anticipated to grow steadily. 

The hirsutism treatment market in North America is anticipated to grow as a result of several important factors. The need for efficient therapies has been fueled by the rising incidence of hirsutism, which is frequently associated with diseases like polycystic ovarian syndrome (PCOS). The tendency of the area to adopt cutting-edge medical technology, such as non-invasive procedures like laser hair removal, helps the industry grow by providing more pleasant and effective options. In addition, a well-established healthcare infrastructure in conjunction with increased public and professional knowledge promotes early diagnosis and easy access to a range of treatment options. The industry is further fueled by changing cultural views that emphasize on appearance and an enhanced need to spend money on cosmetic procedures.

Hirsutism treatment procedures are anticipated to be the fastest-growing segment

Hirsutism treatment procedures that can be used in conjunction with medical therapy and whose effects might persist longer than self-care techniques include:

• Laser Therapy: To cause damage to hair follicles and stop hair growth, a laser beam with a high concentration of light is applied to your skin (photoepilation). The patient may require several treatments.
• Electrolysis: A thin needle is inserted into each hair follicle during this procedure. The follicle is damaged and ultimately destroyed by the electric current pulse that the needle delivers. In contrast to laser therapy, electrolysis is a preferable choice for people with naturally blond or white hair.

Market Key Developments

• In December 2021, Xeris Biopharma Holdings, Inc., a biopharmaceutical company that develops and markets innovative therapies for patient populations in neurology, gastroenterology, and endocrinology, announced that Recorlev® (levoketoconazole) has received FDA approval for treating endogenous hypercortisolemia in adult Cushing's syndrome patients for whom surgery is either not an option or has not proven to be curative.

Segmentation:

• By Treatment Type
  • Medications
  • Procedures
  • Others
• By Application
  • Upper Lip
  • Chin
  • Chest
  • Arms
  • Others
• By End-User
  • Hospitals
  • Dermatology Clinics & Aesthetic Centers
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand